Patient Guide: A Clinical Trial Comparing TQC3927 Inhaled Powder With Glycopyrronium Bromide and Formoterol Inhaled Aerosol (Biovoping® Lingchang®) for the Treatment of Chronic Obstructive Pulmonary Disease

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • ✓ Get matched to the right study location for you
  • ✓ Connect directly with study coordinators at 15 participating sites
  • ✓ Understand eligibility with our simplified screening tool
  • ✓ Free service - we're here to help you access clinical research
Trial ID: NCTNCT07633314
Status: UPCOMING
Condition: Chronic Obstructive Pulmonary Disease
Phase: PHASE2

Find a Study Location Near You

This study is available at 15 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • • Yulin, Guangxi
  • • Daqing, Heilongjiang
  • • Anyang, Henan
  • • And 12 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Clinical Trial Comparing TQC3927 Inhaled Powder With Glycopyrronium Bromide and Formoterol Inhaled Aerosol (Biovoping® Lingchang®) for the Treatment of Chronic Obstructive Pulmonary Disease - Join Clinical Trial NCTNCT07633314

How to Join This Clinical Trial - NCTNCT07633314

Learn how to participate in this PHASE2 trial studying an investigational therapy for Chronic Obstructive Pulmonary Disease. Current status: UPCOMING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Chronic Obstructive Pulmonary Disease. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Chronic Obstructive Pulmonary Disease
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
UPCOMING
Study Identifier
NCTNCT07633314 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 15 locations. Find a study site near you:

Clinical Research Site

Yulin, Guangxi 537000 - China

Status: Contact for availability

Clinical Research Site

Daqing, Heilongjiang 163000 - China

Status: Contact for availability

Clinical Research Site

Anyang, Henan 455099 - China

Status: Contact for availability

Clinical Research Site

Yichang, Hubei 443003 - China

Status: Contact for availability

Clinical Research Site

Xiangtan, Hunan 411200 - China

Status: Contact for availability

Clinical Research Site

Yangzhou, Jiangsu 225000 - China

Status: Contact for availability

Clinical Research Site

Yixing, Jiangsu 214200 - China

Status: Contact for availability

Clinical Research Site

Nanchang, Jiangxi 330000 - China

Status: Contact for availability

Clinical Research Site

Siping, Jilin 136099 - China

Status: Contact for availability

Clinical Research Site

Shanghai, Shanghai Municipality 200433 - China

Status: Contact for availability

And 5 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Chronic Obstructive Pulmonary Disease:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai as Your Clinical Trial Matching Service

Quri.ai is a free clinical trial matching service that helps patients connect with research sites. We make it easier to:

  • Find clinical trials that match your condition
  • Get matched to the right study location near you
  • Connect directly with study coordinators
  • Understand if you qualify with simplified eligibility screening
  • Navigate the enrollment process with personalized support
  • Access new treatments through clinical research participation